GenMark Diagnostics, Inc. (GNMK) Seems To Be Turning Some Investors Off

GenMark Diagnostics, Inc. (GNMK) has seen some recent movement in the stock market and its common shares closed at $11.32 yesterday. Traders are starting to take interest of GNMK as the common shares traded as high as $11.78 and as low as $11.23 in the previous trading day.

GenMark Diagnostics, Inc. (GNMK) average trading volume is 1.17M. However, in the previous trading day GenMark Diagnostics, Inc. (GNMK) traded 768,842 shares. The 1st support level on GNMK is $10.92 and the 1st resistance level on GNMK is $18.92. GNMK 50day moving average is $12.93 and GNMK 200-day moving average is $12.91.

GenMark Diagnostics, Inc. (GNMK) most recent performance has been indicated by the recent movement in GNMK common shares. GNMK has performed -16.86% over the past month, GNMK has performed -37.56% over the past quarter and GNMK has shown 97.38% over the past 12 months. GenMark Diagnostics, Inc. (GNMK) has a 1 year range of $3.36 to $20.88. GenMark Diagnostics, Inc. (GNMK) is trading 236.90% from its 1 year low and -45.79% from its 1 year high. GenMark Diagnostics, Inc. (GNMK) is showing a 12.64% short float showing the amount short in the float.

GNMK has 66.53M shares outstanding and 55.50M shares in the float. GenMark Diagnostics, Inc. (GNMK) at this time has a market cap of $844.02M and income of -33.70M. The EPS next quarter for GNMK is -0.06 and forecasted EPS next year is 53.80%. The market cap of GenMark Diagnostics, Inc. (GNMK) at $844.02M signifies how many Traders own shares of GNMK and is based off the last price ($11.32) of GNMK and the amount of shares outstanding (66.53M) with GenMark Diagnostics, Inc. (GNMK).

GenMark Diagnostics, Inc. (GNMK) has aggregate cash (mrq) of 132.79M, aggregate cash per share (mrq) of 1.87, aggregate debt of GNMK remains at 77.28M and aggregate debt/equity (mrq) is 85.69. . GenMark Diagnostics, Inc. (GNMK) operating cash flow (ttm) is -18.93M, GNMK leveraged free cash flow (ttm) is -3.29M.

GNMK is trading -16.30% below (bearish) its SMA20, -17.22% below (bearish) its SMA50 and 9.69% above (bullish) its SMA200.

Related Articles

Dada Group (NASDAQ: DADA) Extends Partnership With Lianhua Supermarket

Dada Group (NASDAQ: DADA) has disclosed that it has extended its strategic partnership with Lianhua Supermarket Holdings Co., Ltd. Both the companies aimed to focus...

Diana Shipping (NYSE: DSX) Signs Time Charter Contract With CLdN Cobelfret

Diana Shipping (NYSE: DSX) has revealed that it has signed a time charter contract with CLdN Cobelfret SA through its fully-owned unit. US$12,100 is...

Biogen (NASDAQ: BIIB) And Sage Therapeutics Inks Agreement To Develop Therapies For Depression

Biogen Inc. (NASDAQ: BIIB) and Sage Therapeutics, Inc. (NASDAQ: SAGE) communicated that they are partnering together and will be combining their efforts to develop...

Get in Touch

19,000FansLike
35,222FollowersFollow
22,458FollowersFollow

Latest Posts

Dada Group (NASDAQ: DADA) Extends Partnership With Lianhua Supermarket

Dada Group (NASDAQ: DADA) has disclosed that it has extended its strategic partnership with Lianhua Supermarket Holdings Co., Ltd. Both the companies aimed to focus...

Diana Shipping (NYSE: DSX) Signs Time Charter Contract With CLdN Cobelfret

Diana Shipping (NYSE: DSX) has revealed that it has signed a time charter contract with CLdN Cobelfret SA through its fully-owned unit. US$12,100 is...

Biogen (NASDAQ: BIIB) And Sage Therapeutics Inks Agreement To Develop Therapies For Depression

Biogen Inc. (NASDAQ: BIIB) and Sage Therapeutics, Inc. (NASDAQ: SAGE) communicated that they are partnering together and will be combining their efforts to develop...

BBVA And Sabadell Ends Talks Of A Merger Due To Conflict Over Price

Banco Bilbao Vizcaya Argentaria S.A. (NYSE: BBVA) and Banco de Sabadell SA have discussed the terms of a merger but the negotiation turned out...

Hancock Jaffe (NASDAQ: HJLI) Confirms 1:25 Reverse Stock Split

Hancock Jaffe Laboratories, Inc. (NASDAQ: HJLI), a company that manufactures medical devices used to treat heart problems, publicized that its Board of Directors has...